Rohit Kohli
@liver4kids.bsky.social
Assoc. Dir, Saban Research Institute + Chief of GI ChildrensLA || Prof Pediatrics, KeckSchool_USC || Member NAMS_India + AmerPedSociety || Posts≠Endorsement
Pinned
MALRD1 Deficiency Aggravates Hepatic Fibrosis in Diet-Induced MASH - Gastro Hep Advances www.ghadvances.org/article/S277... @dremamaullee.bsky.social @markfrey2000.bsky.social
MALRD1 Deficiency Aggravates Hepatic Fibrosis in Diet-Induced MASH
www.ghadvances.org
November 30, 2025 at 9:24 PM
MALRD1 Deficiency Aggravates Hepatic Fibrosis in Diet-Induced MASH - Gastro Hep Advances www.ghadvances.org/article/S277... @dremamaullee.bsky.social @markfrey2000.bsky.social
September 15, 2025 at 10:43 PM
August 12, 2025 at 12:50 AM
Reposted by Rohit Kohli
Reposted by Rohit Kohli
The Legislature is considering phasing out chemical additives in school meals linked to health problems. Opponents say the definitions are so broad that it could ban items like tomato sauce and olive oil. cal.news/3Glu9bf
📸 Semantha Norris
📸 Semantha Norris
June 27, 2025 at 11:54 PM
The Legislature is considering phasing out chemical additives in school meals linked to health problems. Opponents say the definitions are so broad that it could ban items like tomato sauce and olive oil. cal.news/3Glu9bf
📸 Semantha Norris
📸 Semantha Norris
July 5, 2025 at 12:50 AM
Reposted by Rohit Kohli
Happy 5 year anniversary of the worst Mother’s Day gift I have ever given my wife: The opportunity to perform chest compressions on me for 10 minutes.
May 11, 2025 at 6:19 PM
Happy 5 year anniversary of the worst Mother’s Day gift I have ever given my wife: The opportunity to perform chest compressions on me for 10 minutes.
Full house at #DDW2025 for the #Obesity #Metabolism Section #BasicScience Symposium!
@seeleyrj.bsky.social @vpopovs.bsky.social @andresacosta.bsky.social
@seeleyrj.bsky.social @vpopovs.bsky.social @andresacosta.bsky.social
May 3, 2025 at 8:40 PM
Full house at #DDW2025 for the #Obesity #Metabolism Section #BasicScience Symposium!
@seeleyrj.bsky.social @vpopovs.bsky.social @andresacosta.bsky.social
@seeleyrj.bsky.social @vpopovs.bsky.social @andresacosta.bsky.social
Reposted by Rohit Kohli
New @nejm.org - Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
www.nejm.org/doi/full/10....
#Liversky #Medsky
www.nejm.org/doi/full/10....
#Liversky #Medsky
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis | NEJM
Semaglutide, a glucagon-like peptide-1 receptor agonist, is a candidate for the treatment
of metabolic dysfunction–associated steatohepatitis (MASH). In this ongoing phase
3, multicenter, randomize...
www.nejm.org
May 1, 2025 at 6:07 AM
New @nejm.org - Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
www.nejm.org/doi/full/10....
#Liversky #Medsky
www.nejm.org/doi/full/10....
#Liversky #Medsky
Medical Journals Get Letters From DOJ www.medpagetoday.com/special-repo...
Medical Journals Get Letters From DOJ
At least three journals received letters from a U.S. Attorney asking about 'competing viewpoints'
www.medpagetoday.com
April 21, 2025 at 5:46 AM
Medical Journals Get Letters From DOJ www.medpagetoday.com/special-repo...
Reposted by Rohit Kohli
A novel cyclopeptide that targets FXR-coactivator interaction, reduces ceramides, increases GLP-1, thus paving the way for a new approach to treating MASH with FXR antagonists. @lifemetabolism.bsky.social academic.oup.com/lifemeta/art...
Development of cyclopeptide inhibitors specifically disrupting FXR–coactivator interaction in the intestine as a novel therapeutic strategy for MASH
Abstract. Intestinal farnesoid X receptor (FXR) antagonists have been proven to be efficacious in ameliorating metabolic diseases, particularly for the tre
academic.oup.com
April 15, 2025 at 10:22 AM
A novel cyclopeptide that targets FXR-coactivator interaction, reduces ceramides, increases GLP-1, thus paving the way for a new approach to treating MASH with FXR antagonists. @lifemetabolism.bsky.social academic.oup.com/lifemeta/art...
Reposted by Rohit Kohli
Big congratulations to our 2025 awardees, including Dr. David Lieberman, recipient of AGA’s highest honor — the Julius Friedenwald Medal. 🙌
Join us in celebrating these leaders in GI:
Join us in celebrating these leaders in GI:
Congrats to the 2025 AGA recognition prize recipients
Congrats to Dr. David Lieberman on receiving our highest honor, the Julius Friedenwald Medal.
gastro.org
April 15, 2025 at 12:02 PM
Big congratulations to our 2025 awardees, including Dr. David Lieberman, recipient of AGA’s highest honor — the Julius Friedenwald Medal. 🙌
Join us in celebrating these leaders in GI:
Join us in celebrating these leaders in GI:
pubmed.ncbi.nlm.nih.gov/40222485/ MASH Global Consensus
Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis - PubMed
Our study provides an extensive set of recommendations generated based on a comprehensive review of the most recent MASLD/MASH guidelines and a consensus-building process.
pubmed.ncbi.nlm.nih.gov
April 14, 2025 at 2:16 PM
pubmed.ncbi.nlm.nih.gov/40222485/ MASH Global Consensus
#Global Consensus Recommendations for Metabolic Dysfunction-Associated #Steatotic #Liver Disease and Steatohepatitis - @gastrojournal www.gastrojournal.org/article/S001...
Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and Steatohepatitis
Metabolic dysfunction-associated steatotic liver disease (MASLD) and steatohepatitis
(MASH) are associated with adverse clinical outcomes, impaired health-related quality
of life, and large economic b...
www.gastrojournal.org
April 12, 2025 at 2:11 AM
#Global Consensus Recommendations for Metabolic Dysfunction-Associated #Steatotic #Liver Disease and Steatohepatitis - @gastrojournal www.gastrojournal.org/article/S001...
#Recognition honored to be inducted as a member of the Indian National Academy of Medical Sciences 🙏🏽 nams-india.in
April 9, 2025 at 2:08 PM
#Recognition honored to be inducted as a member of the Indian National Academy of Medical Sciences 🙏🏽 nams-india.in
Reposted by Rohit Kohli
Calling all interested fellows! JPGN Reports is looking for a 3rd + 4th year GI fellow to apply for the fellow editor program! 📝The outgoing fellow editor is finishing up this first-rate experience! So get your CV, letter of interest, + letter of support to apply today! applications due 6/27/2025. ✒️
March 25, 2025 at 5:29 PM
Calling all interested fellows! JPGN Reports is looking for a 3rd + 4th year GI fellow to apply for the fellow editor program! 📝The outgoing fellow editor is finishing up this first-rate experience! So get your CV, letter of interest, + letter of support to apply today! applications due 6/27/2025. ✒️
www.chla.org/event/genera... #pediatric #family #liver #education @livercoalition.bsky.social @naspghan.bsky.social
Biliary Atresia Day 2025
This event is a day for families affected by biliary atresia to learn more, hear from experts, and connect with other families. This event is free and open to all families affected by biliary atresia.
www.chla.org
March 26, 2025 at 2:47 AM
Reposted by Rohit Kohli
Surprising insights from CHOP's John Lab show how a novel prodrug strategy for treating #malaria could help researchers design more effective drugs for the deadly disease. Learn more about the PNAS study in a new Snapshot Science blog: http://ms.spr.ly/63325qJHSW
March 8, 2025 at 1:00 PM
Surprising insights from CHOP's John Lab show how a novel prodrug strategy for treating #malaria could help researchers design more effective drugs for the deadly disease. Learn more about the PNAS study in a new Snapshot Science blog: http://ms.spr.ly/63325qJHSW